Beata Kruk

409 total citations
17 papers, 144 citations indexed

About

Beata Kruk is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Beata Kruk has authored 17 papers receiving a total of 144 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 12 papers in Hepatology and 4 papers in Surgery. Recurrent topics in Beata Kruk's work include Liver Disease Diagnosis and Treatment (12 papers), Liver Diseases and Immunity (11 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Beata Kruk is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Liver Diseases and Immunity (11 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Beata Kruk collaborates with scholars based in Poland, Germany and Denmark. Beata Kruk's co-authors include Marcin Krawczyk, Piotr Milkiewicz, Joanna Raszeja‐Wyszomirska, Frank Lammert, Maciej K. Janik, Ewa Wunsch, Barbara Górnicka, Stéphanie Roessler, Chiara Braconi and Jesper B. Andersen and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Beata Kruk

16 papers receiving 143 citations

Peers

Beata Kruk

EPIDE

HEPAT

SURGE

ONCOL

Álvaro Giráldez Gallego Spain

Kazuki Ohya Japan

Raffaella Viganò Italy

Maaike Biewenga Netherlands

Guilherme Rezende Brazil

Hussa Alhussaini Saudi Arabia

Alexander Nersesov Kazakhstan

Manon Allaire France

Reona Morio Japan

Nancy Kwan Man Hong Kong

Álvaro Giráldez Gallego Spain

Beata Kruk

67 ×0.7

EPIDE

47 ×0.6

HEPAT

33 ×0.6

SURGE

15 ×0.6

ONCOL

20 ×1.8

Citations per year, relative to Beata Kruk Beata Kruk (= 1×) peers Álvaro Giráldez Gallego

Countries citing papers authored by Beata Kruk

Since Specialization

Citations

This map shows the geographic impact of Beata Kruk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beata Kruk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beata Kruk more than expected).

Fields of papers citing papers by Beata Kruk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beata Kruk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beata Kruk. The network helps show where Beata Kruk may publish in the future.

Co-authorship network of co-authors of Beata Kruk

This figure shows the co-authorship network connecting the top 25 collaborators of Beata Kruk. A scholar is included among the top collaborators of Beata Kruk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beata Kruk. Beata Kruk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Kruk, Beata, Joanna Raszeja‐Wyszomirska, Marcin Krawczyk, & Piotr Milkiewicz. (2025). Fatigue and itch severity in patients with PBC and PSC: Prospective analysis of two large cohorts. European Journal of Clinical Investigation. 55(7). e70041–e70041. 1 indexed citations

Kalinowski, Piotr, Agnieszka Karkucińska‐Więckowska, Inês C. M. Simões, et al.. (2024). Oxidative stress in metabolic dysfunction‐associated steatotic liver disease ( MASLD ): How does the animal model resemble human disease?. The FASEB Journal. 38(3). e23466–e23466. 14 indexed citations

Krupa, Łukasz, Piotr Kalinowski, Joanna Ligocka, et al.. (2024). The ABCG8 polymorphism increases the risk of gallbladder cancer in the general population and gallstones in obese patients from Poland. European Journal of Clinical Investigation. 54(8). e14213–e14213. 2 indexed citations

Xia, C., Marcin Krawczyk, Łukasz Krupa, et al.. (2024). Loss of mucosal tolerance to glycoprotein 2 isoform 1 is a potential novel diagnostic biomarker for cholangiocarcinoma. Digestive and Liver Disease. 57(1). 14–22.

Wunsch, Ewa, Beata Kruk, Katarzyna Fischer, et al.. (2024). THU-095 Novel machine learning algorithm for risk prediction of cholangiocarcinoma in primary sclerosing cholangitis. Journal of Hepatology. 80. S308–S308. 1 indexed citations

Kruk, Beata, Małgorzata Milkiewicz, Joanna Raszeja‐Wyszomirska, Piotr Milkiewicz, & Marcin Krawczyk. (2022). A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients. Orphanet Journal of Rare Diseases. 17(1). 419–419. 7 indexed citations

Wronka, Karolina M., et al.. (2021). Dehydroepiandrosterone sulfate indicates decreased sulfation capacity and impaired quality of life in Primary Sclerosing Cholangitis. Polskie Archiwum Medycyny Wewnętrznej. 131(9). 790–796. 3 indexed citations

Janik, Maciej K., Beata Kruk, Barbara Górnicka, et al.. (2021). MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis. Scientific Reports. 11(1). 24407–24407. 11 indexed citations

Wunsch, Ewa, Beata Kruk, Katarzyna Kotarska, et al.. (2021). Chronic Fatigue Persists in a Significant Proportion of Female Patients After Transplantation for Primary Sclerosing Cholangitis. Liver Transplantation. 27(7). 1032–1040. 7 indexed citations

10.

Janik, Maciej K., Beata Kruk, Barbara Górnicka, et al.. (2021). MARC1 p.A165T polymorphism is associated with decreased liver injury and enhanced antioxidant activity in serum in patients with AIH. Zeitschrift für Gastroenterologie. 2 indexed citations

11.

Wunsch, Ewa, Beata Kruk, Emilian Snarski, et al.. (2020). Plasmapheresis improves chronic fatigue in patients with primary biliary cholangitis. Polskie Archiwum Medycyny Wewnętrznej. 131(2). 205–207. 4 indexed citations

12.

Janik, Maciej K., Beata Kruk, Joanna Raszeja‐Wyszomirska, et al.. (2020). Measurement of liver and spleen stiffness as complementary methods for assessment of liver fibrosis in autoimmune hepatitis. Liver International. 41(2). 348–356. 24 indexed citations

13.

Janik, Maciej K., Beata Kruk, Barbara Górnicka, et al.. (2020). Simultaneous liver and spleen stiffness measurements as complementary methods for fibrosis quantification in autoimmune hepatitis. Journal of Hepatology. 73. S484–S485. 1 indexed citations

14.

Braconi, Chiara, Stéphanie Roessler, Beata Kruk, et al.. (2019). Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?. Liver International. 39(S1). 32–42. 19 indexed citations

15.

Janik, Maciej K., Ewa Wunsch, Joanna Raszeja‐Wyszomirska, et al.. (2018). Autoimmune hepatitis exerts a profound, negative effect on health‐related quality of life: A prospective, single‐centre study. Liver International. 39(1). 215–221. 36 indexed citations

16.

Kruk, Beata, Roman Liebe, Małgorzata Milkiewicz, et al.. (2018). PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC. PLoS ONE. 13(8). e0202942–e0202942. 7 indexed citations

17.

Liebe, Roman, Marcin Krawczyk, Joanna Raszeja‐Wyszomirska, et al.. (2016). Heterozygous Inactivation of the Nuclear Receptor PXR/NR1I2 in a Patient With Anabolic Steroid-Induced Intrahepatic Cholestasis. Hepatitis Monthly. 16(8). e35953–e35953. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact